Robuta

https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-seeks-dcgi-approval-for-its-oral-pill-to-treat-anemia-due-to-ckd/87869471 Kidney Diseases: Zydus Cadila seeks DCGI approval for its oral pill to treat anemia due to CKD,... Kidney Diseases: Zydus Cadila is seeking approval for Desidustat an oral pill alternative for the treatment of anemia due to Chronic Kidney Disease (CKD) in... https://health.economictimes.indiatimes.com/news/pharma/cadila-arm-completes-sale-of-animal-health-business-for-rs-2921-crore/84439792 Zydus Animal Health And Investment: Cadila arm completes sale of animal health business for Rs... In May this year, Zydus Animal Health and Investment has entered into definitive pacts for sale of its animal healthcare established markets undertaking to... https://health.economictimes.indiatimes.com/news/pharma/cadila-pharmaceuticals-launches-tarzed-for-breast-cancer/88727104 Cadila Pharmaceuticals launches Tarzed for breast cancer, ETHealthworld Tarzed a humanized monoclonal antibody is available as 440 mg injection. cadila pharmaceuticalsbreast cancerlaunches https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-gets-american-health-regulators-approval-to-market-mineral-supplement/78183277 Zydus Cadila gets American health regulator's approval to market mineral supplement, ETHealthworld Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Potassium Chloride extended release tablets in the... https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-launches-generic-prostate-cancer-drug-at-nearly-70-less-price-in-india/75639941 Zydus Cadila launches generic prostate cancer drug at nearly 70% less price in India, ETHealthworld "Our aim is to make a preferred choice of therapy like Obynx available and more accessible to people suffering from cancer. Bridging these unmet gaps comes... https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-gets-tentative-nod-from-usfda-to-market-cancer-drug/84614124 Zydus Cadila gets tentative nod from USFDA to market cancer drug, ETHealthworld The company has received tentative approval from the United States Food and Drug Administration (USFDA) to market Ibrutinib tablets, in the strengths of 140... zydus cadila https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-gets-tentative-usfda-nod-to-market-lung-cancer-treatment-drug/83201464 Us Food And Drug Administration: Zydus Cadila gets tentative USFDA nod to market lung cancer... The company has received tentative approval from the US Food and Drug Administration (USFDA) to market Osimertinib tablets in the strengths of 40 mg and 80 mg,... food and drug administration https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-says-positive-results-from-phase-2-studies-of-covid-19-drug-desidustat-in-mexico/80446372 Covid Vaccine: Zydus Cadila says 'positive results' from phase 2 studies of Covid-19 drug... Covid Vaccine: In June 2020, Zydus Cadila had received approval from Mexico's regulatory authority Cofepris to test one of its lead research candidate... https://hr.economictimes.indiatimes.com/tag/zydus+cadila+healthcare+limited Zydus cadila healthcare limited - Latest zydus cadila healthcare limited , Information & Updates -... ETHRWorld.com brings latest zydus cadila healthcare limited news, views and updates from all top sources for the Indian HR industry. zydus cadilalatest informationhealthcarelimitedupdates https://economictimes.indiatimes.com/zydus-lifesciences-ltd/stocks/companyid-3778.cms Cadila Healthcare Share Price Today, Cadila Healthcare Stock Price Live NSE/BSE Updates | The... Cadila Healthcare Share Price Today - Get live NSE/BSE quotes of Cadila Healthcare with latest news, headlines and quick analysis. View forecasts, quarterly... share pricecadilahealthcaretoday https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-gets-usfda-nod-for-manufacturing-doxycycline-injection-at-vadodara/76996737 Zydus Cadila gets USFDA nod for manufacturing Doxycycline Injection at Vadodara, ETHealthworld Doxycycline Injection is used to treat or prevent bacterial infections, including pneumonia and other respiratory tract infections. zydus cadilafor manufacturing https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-launches-indias-cheapest-remdesivir-version-at-rs-2800-per-100-mg-vial/77520875 Zydus Cadila launches India's cheapest remdesivir version at Rs 2,800 per 100 mg vial, ETHealthworld Zydus is the fifth company to launch a copy of the antiviral in India after privately held Hetero Labs Ltd, Cipla, Mylan NV and Jubilant Life Sciences Ltd.... https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-gets-tentative-usfda-nod-to-market-anti-cancer-drug/78291575 Zydus Cadila gets tentative USFDA nod to market anti-cancer drug, ETHealthworld Drug firm Zydus Cadila on Thursday said it has received tentative approval from the US health regulator to market anti-cancer drug Palbociclib Capsules. zydus cadila https://www.business-standard.com/article/companies/zydus-cadila-gets-usfda-nod-to-market-mineral-supplement-tablets-120091800444_1.html Zydus Cadila gets USFDA nod to market mineral supplement tablets | Company News - Business Standard Zydus Cadila said it has received approval from USFDA to market potassium chloride extended release tablets, a mineral supplement used to treat or prevent low... https://www.financialexpress.com/business/healthcare-cadila-pharma-launches-generic-versions-of-sitagliptin-for-type-2-diabetes-in-india-2614414/ Cadila Pharma launches generic versions of sitagliptin for type 2 diabetes in India - Healthcare... Meanwhile, the company has also launched a potent combination of Sitagliptin and Metformin and branded it as Jankey M. https://health.economictimes.indiatimes.com/tag/zydus+cadila+moraiya Zydus cadila moraiya - Latest zydus cadila moraiya , Information & Updates - Health -ET HealthWorld ETHealthworld.com brings latest zydus cadila moraiya news, views and updates from all top sources for the Indian Health industry. zydus cadilalatest informationmoraiyaupdateshealth https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-gets-tentative-nod-from-usfda-to-market-diabetes-drug/78928067 Zydus Cadila gets tentative nod from USFDA to market diabetes drug, ETHealthworld Zydus Cadila: The company said the newly approved medication will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad. zydus cadila https://health.economictimes.indiatimes.com/news/pharma/usfda-grants-orphan-drug-designation-to-zydus-cadilas-saroglitazar-mg/80506195 Zydus Group: USFDA grants orphan drug designation to Zydus Cadila's Saroglitazar Mg, ETHealthworld Zydus Group: Zydus Cadila, which is a part of Cadila Group, said orphan drug designation provides eligibility for certain development incentives, including tax... orphan drug designation https://health.economictimes.indiatimes.com/news/pharma/cadila-pharma-appoints-ashraf-allam-global-coo/96355397 Cadila Pharma appoints Ashraf Allam global COO, ETHealthworld Cadila Pharmaceuticals on Monday said it has appointed Ashraf Allam as its global Chief Operating Officer (COO). Previously he has worked with multinationals... cadilapharmaappointsashrafallam https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-gets-usfda-nod-for-antidepressant-drug/81210183 Zydus Cadila | USFDA: Zydus Cadila gets USFDA nod for antidepressant drug, ETHealthworld Zydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Nortriptyline Hydrochloride capsules USP, in... zydus cadilausfdagetsnodantidepressant https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/efforts-being-ramped-up-for-massive-production-of-vaccines-make-them-available-quickly-dbt-secretary/articleshow/82182341.cms Zydus Cadila: Efforts being ramped up for massive production of vaccines, make them available... Department of Biotechnology Secretary Renu Swarup said a financial support of Rs 400 crore is being provided to vaccine candidates from Zydus Cadilla,... https://adisinsight.springer.com/drugs/800055423?error=cookies_not_supported&code=eea18929-35e1-4d63-90ce-47c5174c60cd Pertuzumab biosimilar - Zydus Cadila - AdisInsight ZRC 3277 is a biosimilar version of pertuzumab [see AdisInsight drug profile 800014629], being developed by Zydus Cadila, for the treatment of breast cancer, zydus cadilapertuzumabbiosimilaradisinsight